Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer (NCT05714891)

🧪 Interventions in This Study

• JDQ443 (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (8 Sites)

• CancerCare Manitoba — Winnipeg, Manitoba
• Kingston Health Sciences Centre — Kingston, Ontario
• London Health Sciences Centre Research Inc. — London, Ontario
• Ottawa Hospital Research Institute — Ottawa, Ontario
• University Health Network — Toronto, Ontario
• CHUM-Centre Hospitalier de l'Universite de Montreal — Montreal, Quebec
• The Research Institute of the McGill University — Montreal, Quebec
• University Institute of Cardiology and — Québec, Quebec

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in NSCLC

• Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy — Savannah, Georgia
• A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC — Daphne, Alabama
• Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC — La Jolla, California
• A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care — Boston, Massachusetts
• Study of Oral MRT-2359 in Selected Cancer Patients — Scottsdale, Arizona
• Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations — Phoenix, Arizona

Explore by condition: All NSCLC clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.